All News

Eight Sleep Raises $100M to Scale AI-Powered Sleep Tech

Eight Sleep raised $100 million to accelerate its AI-powered Pod mattress and a new Sleep Agent that creates digital twins for personalized nightly interventions. The company cites $500M in Pod sales, a tenfold revenue jump since 2019, and insights from over one billion recorded sleep hours. Plans include FDA pursuits, China expansion, contactless apnea solutions, and privacy-first data handling.

Published August 19, 2025 at 07:10 AM EDT in Artificial Intelligence (AI)

Eight Sleep raises $100M to scale AI-powered sleep technology

Roughly one in three U.S. adults regularly gets insufficient sleep, and that demand is creating a bigger market for devices that monitor, analyze, and improve rest. New York–based Eight Sleep, founded in 2014, announced a fresh $100 million funding round led by investors including HSG, Valor Equity Partners, Founders Fund, Y Combinator, and public figures such as F1 drivers Charles Leclerc and Zak Brown.

The raise brings Eight Sleep’s total financing to about $260 million, and the company says its valuation has roughly doubled since its 2021 Series C (which had a reported $500 million post-money mark). Cofounder and CMO Alexandra Zatarain framed the round as fuel for international expansion, medical-sector growth, and execution of an AI roadmap that could push the company into unicorn territory.

Eight Sleep’s flagship product, the Pod, blends embedded sensors and software to turn a mattress into a passive health device. The system measures sleep stages, heart rate, breathing patterns, movement, and snoring. Using those signals, it can automatically adjust temperature, base elevation, and firmness; detect snoring and raise the head of the bed; and, with the new Health Check feature, claim high-accuracy cardiovascular and respiratory monitoring without wearables.

The business case is tangible: Eight reports more than $500 million in Pod sales, a tenfold revenue increase since 2019, and insights drawn from over one billion hours of recorded sleep data. The company operates with just over 100 full-time employees while scaling both product and clinical ambitions.

On the technical front, Eight is shifting from passive tracking to proactive optimization. Its Sleep Agent leverages large language models to generate thousands of digital twins per user, simulate outcomes, and recommend personalized nightly recovery interventions — effectively predicting how a given temperature or elevation change will impact that person’s physiology.

Eight is also positioning the Pod for medical workflows. The company is pursuing FDA pathways for contactless sleep apnea solutions and clinical-grade monitoring, has launched a Hot Flash Mode for menopause relief using AI-driven cooling, and says its Health Check can detect cardiopulmonary trends at high accuracy to prompt early clinical follow-up.

Competition is broad: wearables (Oura, Fitbit, Apple), medical-device incumbents (ResMed), and other sleep-surface makers (Sleep Number, ChiliSleep). Eight’s core differentiator is a tightly integrated hardware-plus-AI stack — Autopilot builds a personal blueprint from night one, adapts continuously for travel, stress, training, or illness, and works independently for each side of a bed.

The company currently ships to more than 30 countries and is targeting China next, citing a health-conscious middle class. On privacy, Eight stresses encryption, no microphones, GDPR and CCPA compliance, and that biometric sensors are embedded in the mattress surface rather than requiring wearables.

What this means for the broader tech and health ecosystem:

  • Health systems: continuous, passive monitoring could enable earlier interventions and richer longitudinal records if clinically validated.
  • Device makers: digital twin models create opportunities for personalization, simulation-driven product features, and predictive maintenance.
  • Regulators and payers: next-gen sleep devices will need transparent validation, privacy safeguards, and clear evidence of clinical utility.
  • Employers and insurers: validated recovery metrics could be folded into wellness programs, but only with robust privacy controls and demonstrated outcomes.

For organizations evaluating this space, the immediate questions are technical and operational: how to ingest and store continuous biometric streams securely, how to validate AI-driven interventions against clinical endpoints, and how to design trials or pilots that satisfy regulators and payers. There's also a competitive design angle — will winners be the companies with the best models, the most robust privacy posture, or the strongest clinical partnerships?

QuarkyByte’s approach translates these questions into practical roadmaps. We map data architectures that preserve patient privacy while enabling model training; we stress-test clinical endpoints and evidence plans; and we convert digital twin concepts into measurable pilot metrics. Eight Sleep’s latest raise signals a shift: sleep tech is maturing into regulated, data-rich health infrastructure where rigorous engineering, privacy-by-design, and clinical proof will separate hype from impact.

Keep Reading

View All
The Future of Business is AI

AI Tools Built for Agencies That Move Fast.

QuarkyByte can model how Eight Sleep–style sensor data and LLM-driven digital twins plug into clinical validation, regulatory strategy, and production data pipelines. We help device teams and health systems design privacy-first pilots, quantify clinical impact, and map pathways to scale and compliance.